Organogenesis Holdings Inc.
ORGO
$1.79
$0.031.71%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 454.61M | 512.59M | 563.03M | 464.62M | 429.31M |
| Total Other Revenue | 2.84M | 2.12M | 1.14M | 603.00K | 226.00K |
| Total Revenue | 457.45M | 514.70M | 564.17M | 465.22M | 429.53M |
| Cost of Revenue | 130.43M | 134.39M | 132.34M | 118.66M | 109.20M |
| Gross Profit | 327.02M | 380.31M | 431.83M | 346.56M | 320.33M |
| SG&A Expenses | 298.55M | 318.40M | 325.72M | 299.40M | 291.97M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 485.95M | 501.85M | 502.60M | 463.84M | 444.08M |
| Operating Income | -28.50M | 12.85M | 61.57M | 1.38M | -14.55M |
| Income Before Tax | -34.77M | 4.28M | 46.97M | -6.20M | -21.54M |
| Income Tax Expenses | 49.39M | 1.56M | 9.94M | -7.21M | -13.31M |
| Earnings from Continuing Operations | -84.16 | 2.72 | 37.03 | 1.01 | -8.23 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -84.16M | 2.72M | 37.03M | 1.01M | -8.23M |
| EBIT | -28.50M | 12.85M | 61.57M | 1.38M | -14.55M |
| EBITDA | -9.70M | 32.15M | 80.16M | 19.56M | 3.17M |
| EPS Basic | -0.82 | -0.14 | 0.12 | -0.11 | -0.13 |
| Normalized Basic EPS | -0.13 | 0.07 | 0.31 | 0.02 | -0.07 |
| EPS Diluted | -0.84 | -0.16 | 0.11 | -0.12 | -0.14 |
| Normalized Diluted EPS | -0.15 | 0.06 | 0.30 | 0.01 | -0.07 |
| Average Basic Shares Outstanding | 510.27M | 508.45M | 506.94M | 509.71M | 515.40M |
| Average Diluted Shares Outstanding | 519.53M | 517.71M | 516.21M | 516.16M | 519.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |